Correlation Between Ruentex Development and Alar Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Ruentex Development and Alar Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ruentex Development and Alar Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ruentex Development Co and Alar Pharmaceuticals, you can compare the effects of market volatilities on Ruentex Development and Alar Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ruentex Development with a short position of Alar Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ruentex Development and Alar Pharmaceuticals.

Diversification Opportunities for Ruentex Development and Alar Pharmaceuticals

0.52

Correlation Coefficient

Ruentex Development  Alar Pharmaceuticals

Very weak diversification

The 3 months correlation between Ruentex and Alar is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Ruentex Development Co and Alar Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alar Pharmaceuticals and Ruentex Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ruentex Development Co are associated (or correlated) with Alar Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alar Pharmaceuticals has no effect on the direction of Ruentex Development i.e., Ruentex Development and Alar Pharmaceuticals go up and down completely randomly.

Pair Corralation between Ruentex Development and Alar Pharmaceuticals

Assuming the 90 days trading horizon Ruentex Development is expected to generate 8.87 times less return on investment than Alar Pharmaceuticals. But when comparing it to its historical volatility, Ruentex Development Co is 2.26 times less risky than Alar Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Alar Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  10,393  in Alar Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of  5,057  from holding Alar Pharmaceuticals or generate 48.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	99.79%
Values	Daily Returns

Ruentex Development Co  vs.  Alar Pharmaceuticals

Ruentex Development

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ruentex Development Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Ruentex Development is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Alar Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Alar Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Ruentex Development and Alar Pharmaceuticals

The main advantage of trading using opposite Ruentex Development and Alar Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ruentex Development position performs unexpectedly, Alar Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alar Pharmaceuticals will offset losses from the drop in Alar Pharmaceuticals' long position.

The idea behind Ruentex Development Co and Alar Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.